key: cord-0778074-g07gkr68
authors: Rodríguez-Jiménez, Pedro; Chicharro, Pablo; Martos-Cabrera, Luisa; Seguí, Mireia; Caballero, Álvaro Morales; Llamas-Velasco, Mar; Sánchez-Pérez, Javier
title: Varicella-zoster virus reactivation after SARS-Cov2 BNT162b2 mRNA vaccination: Report of five cases.
date: 2021-04-24
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.04.014
sha: 27a180b8f9a3839fbda77255bbd71a7a3a76cfdc
doc_id: 778074
cord_uid: g07gkr68

nan

We reported a few months ago that to consider vesicular exanthems associated with 28 COVID-19, varicella-zoster virus (VZV) and herpes simplex virus must be ruled out 1 . 29

The natural history of herpes zoster is influenced by the immune status of the host. 30

Reactivation is influenced by age-related immunosenescence, disease-related 31 immunocompromise, or iatrogenic immunosuppression, with age being the major risk 32 factor for most cases of herpes zoster. Among VZV reactivation triggers, vaccines are 33 not a common one, and excluding herpes zoster appearing after VZV vaccination, we 34 have only found one case of a child that experienced herpes zoster after In SARS-Cov2 naturally infected patients, a cytokine storm occurs that involves a 49 considerable release of proinflammatory cytokines including IL-6, TNF-α, and IL-12 50 that could favor VZV reactivation. In the above mentioned report 1 , we hypothesized that 51 the SARS-Cov2 infection characteristically produces lymphopenia, a known factor 52 favoring VZV recurrences. Fernandez-Nieto D et al 5 also described 7 cases of herpes 53 zoster in COVID-19 infected patients. Of note, in the COVID-PIEL study that tried to 54 summarize and classify the different cutaneous manifestations of COVID infection, a 55 perceived increase in the cases of herpes zoster in infected patients was remarked 6 . In 56 our geographical area, the standardized annual herpes zoster incidence rates in Madrid adverse event reporting method did not specify the type of adverse event but just the 62 

To consider varicella-like exanthem associated with 80 COVID-19, virus varicella zoster and virus herpes simplex must be ruled out

Varicella-zoster reactivation in a patient receiving routine 84 revaccinations after an allogeneic hemopoietic progenitors transplant

Herpes zoster following inactivated COVID-19 88 vaccine: A coexistence or coincidence?

Safety and Efficacy of 95 the BNT162b2 mRNA Covid-19 Vaccine

To consider varicella-99 like exanthem associated with COVID-19, virus varicella zoster and virus herpes 100 simplex must be ruled out. Characterization of herpetic lesions in hospitalized

COVID-19 patients

Varicella and 115 herpes zoster in Madrid, based on the Sentinel General Practitioner Network